Intravital Imaging of Attenuated Auxotrophic Mycobacterium tuberculosis in Murine Lung during Early Intravascular Infection
June 30th, 2026
81 views
Here, we present a protocol for intravital imaging of an attenuated BSL-2-approved Mycobacterium tuberculosis. strain in the murine lung using a permanent lung window. This approach enables longitudinal, single-cell-resolution analysis of early host-pathogen interactions, including bacillary localization, vascular dynamics, and macrophage uptake within the same lung microenvironment.
Overview
This article presents a protocol for real-time intravital imaging of Mycobacterium tuberculosis (Mtb) infection dynamics in the murine lung using a BSL-2-compatible system. By combining the thoracic Window for High-Resolution Imaging of the murine Lung (WHRIL) with a genetically defined, attenuated Mtb strain, researchers can visualize host-pathogen interactions at single-cell resolution over the early stages of infection.
Key Study Components
Area of Science
- Infectious disease research
- Immunology
- Intravital microscopy
- Microbiology
Background
- Intravital microscopy allows direct observation of cellular processes in living tissues.
- Studying Mtb in vivo has been limited by BSL-3 containment requirements and technical challenges in lung imaging.
- Traditional imaging approaches lack the resolution and safety for dynamic studies of Mtb infection in the lung.
- Genetically attenuated Mtb strains can potentially be used under lower biosafety conditions.
Purpose of Study
- To develop a BSL-2-compatible protocol for high-resolution, real-time imaging of Mtb infection in the murine lung.
- To enable longitudinal visualization of both bacterial and host cell dynamics during early infection.
- To overcome technical and biosafety limitations of previous intravital imaging approaches for Mtb.
Methods Used
- Use of the WHRIL (thoracic window) for stabilizing the murine lung during imaging.
- Application of mc27902, a triple-auxotrophic, genetically defined Mtb strain approved for BSL-2 use.
- Generation of mc28471, a tdTomato-expressing derivative for fluorescent visualization.
- Intravenous infection of mice and intravital imaging in reporter mouse models.
Main Results
- Enabled real-time visualization of early Mtb infection events in the lung.
- Observed rapid entry of bacilli into the pulmonary vasculature, aggregation, dissemination, and macrophage uptake.
- Achieved single-cell resolution imaging of both bacteria and host cells over the first 3 days post-infection.
- Demonstrated the feasibility of longitudinal studies in the same lung microenvironment.
Conclusions
- This protocol provides a practical, BSL-2-compatible platform for intravital imaging of attenuated mycobacteria in the lung.
- It enables detailed mechanistic studies of bacterial physiology, host recognition, and immune clearance.
- The approach overcomes key limitations of conventional imaging and high-containment models for Mtb research.
Frequently Asked Questions
What is the main advantage of using the WHRIL system with attenuated Mtb strains?
It allows high-resolution, real-time imaging of Mtb infection dynamics in the lung under BSL-2 conditions, overcoming biosafety and technical barriers.
What is mc27902 and why is it important?
mc27902 is a genetically defined, triple-auxotrophic Mtb strain approved for BSL-2 use, enabling safer in vivo studies of tuberculosis infection.
How does the tdTomato-expressing mc28471 strain contribute to the study?
The tdTomato-expressing strain allows fluorescent visualization of Mtb, facilitating tracking of bacterial dynamics during infection.
What infection events can be visualized with this protocol?
Researchers can observe bacillary entry into the vasculature, aggregation, dissemination into lung tissue, and uptake by macrophages in real time.
How does this approach improve upon conventional imaging methods for Mtb?
It enables longitudinal, single-cell resolution imaging in living animals without the need for BSL-3 containment, allowing more detailed and dynamic studies.
What types of mechanistic studies does this protocol facilitate?
It supports studies of bacterial physiology, host-pathogen recognition, and immune-mediated clearance during early Mtb infection.
Executive Industry Relevance
Direct, real-time visualization of host-pathogen interactions in the lung is a critical bottleneck for tuberculosis drug discovery and immunology research. This BSL-2-compatible intravital imaging platform enables longitudinal, single-cell resolution studies of early Mycobacterium tuberculosis infection dynamics in vivo. The approach de-risks early discovery by providing actionable insights into bacterial dissemination, immune cell engagement, and mechanistic host responses in a physiologically relevant setting.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of host-pathogen interactions and immune recognition in the lung microenvironment.
- Supports mechanistic de-risking by visualizing bacterial entry, aggregation, and macrophage uptake in real time.
- Facilitates functional target validation by linking molecular interventions to observable infection dynamics.
Screening & Assay Development
- Provides a validated, reproducible platform for quantitative imaging of bacterial and host cell behaviors.
- Enables standardization of infection models for downstream screening of immunomodulators or anti-infectives.
- Supports assay scalability and platform reuse by leveraging BSL-2-compatible genetically defined strains.
Translational & Preclinical Research
- Aligns preclinical models with disease-relevant infection dynamics and immune responses.
- Enables continuity from discovery through preclinical validation by supporting longitudinal studies in the same animal.
- Improves predictive confidence for translational biomarker identification and mechanistic studies of immune clearance.
Pipeline & Workflow Integration
This imaging protocol bridges early discovery, target validation, and preclinical research by enabling real-time, quantitative analysis of infection and immune response in vivo.
- Discovery Biology: Supports hypothesis testing and mechanistic clarification of host-pathogen interactions.
- Screening: Delivers reproducible, quantitative imaging outputs for comparative analysis of interventions.
- Analytics: Provides single-cell resolution data on bacterial dissemination and immune cell uptake.
- Translational Research: Facilitates alignment of preclinical models with human disease-relevant infection dynamics.
- Enterprise Reuse: Establishes a reusable, BSL-2-compatible imaging platform for diverse mechanistic studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in infection biology.
- Operational Value: Enables standardized, scalable, and reproducible imaging workflows under BSL-2 conditions.
- Strategic Value: Supports better go/no-go decisions and reduces late-stage biological risk in infectious disease portfolios.
- Portfolio Impact: Informs risk-adjusted prioritization and advancement of immunomodulatory or anti-infective candidates.
Implementation Considerations
- Requires expertise in intravital microscopy and murine infection models.
- Needs access to advanced imaging instrumentation and BSL-2 laboratory infrastructure.
- Demands cross-team standardization for imaging protocols and data analysis.
- Adaptation may be needed for different bacterial strains or host genetic backgrounds.
- Imaging is limited to early infection stages and attenuated, genetically defined strains.
Biopharma FAQs
Why does null hypothesis testing matter for intravital imaging of Mtb infection?
Null hypothesis testing enables objective evaluation of whether observed infection dynamics, such as bacillary entry or macrophage uptake, differ significantly between experimental conditions or interventions. This statistical rigor is essential for target validation and mechanistic de-risking in early discovery.
How does independent variable isolation fit the WHRIL-mc27902 infection workflow?
Isolating variables such as bacterial strain, infection dose, or host genotype allows researchers to attribute observed changes in infection dynamics directly to specific experimental manipulations, supporting robust discovery-stage decision making.
What do quantitative dependent variable measurements enable in this imaging protocol?
Quantitative measurements, such as bacillary aggregation or macrophage uptake rates, provide actionable data for comparing interventions, optimizing models, and informing go/no-go decisions in the discovery pipeline.
Why are replication requirements critical for cross-functional collaboration in intravital Mtb studies?
Replication ensures that observed infection dynamics and host responses are reproducible across experiments and teams, enabling reliable data sharing and integration into broader R&D workflows.
What statistical analysis capabilities are required before implementing this intravital imaging protocol?
Teams need robust statistical tools for analyzing longitudinal imaging data, comparing infection dynamics across groups, and validating mechanistic hypotheses, ensuring that findings are both reproducible and actionable for portfolio advancement.
